Clinical Trial Update: Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count [Phase 3]

View source ↗

Summary

Phase 3 trial update on preventing infection in patients with hematologic cancers and leukopenia-related fever; the study has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Multiple Myeloma
• Myelodysplastic Syndromes

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Bone Marrow Suppression, Fever, Sweats, and Hot Flashes | Phase 3 | Status: COMPLETED